Vice President, Finance
Thu, Feb 6, 2020
Feb 6
exercised or converted securities in PCRX
830 shares @ $10.81
Increased holdings by +7.90%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+2.95%
1M-7.55%
3M-1.79%
6M—
1Y—